Division of Cardiovascular Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; Section of Cardiovascular Medicine, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin.
Division of Cardiology, University of California San Diego, San Diego, California.
Heart Rhythm. 2018 Jun;15(6):847-854. doi: 10.1016/j.hrthm.2017.09.043. Epub 2017 Oct 5.
Long-term outcomes and predictors of mortality after implantable cardioverter-defibrillator (ICD) implantation related complication are unclear.
The purpose of this study was to determine the risk of mortality and hospitalization after complication during ICD implantation and identify predictors of adverse outcomes.
We performed a retrospective registry study of Medicare beneficiaries who were first-time ICD recipients enrolled in the National Cardiovascular Data Registry ICD Registry between January 2006 and March 2010. Mortality and hospitalization rates were examined using Kaplan-Meier survival analysis and multivariable Cox proportional hazards regression analysis. Covariates associated with mortality 3 years after ICD implantation complication were investigated.
The study cohort comprised 136,143 Medicare beneficiaries. Complications during the index hospitalization occurred in 7046 patients (5.18%), and complications within 90 days of device implantation occurred in 10,005 patients (7.34%). In adjusted analyses, complications within 90 days of implantation were associated with an increased risk of all-cause mortality at 1 year (hazard ratio [HR] 1.13; 95% confidence interval [CI] 1.05-1.20; P = .006) and 3 years (HR 1.09; 95% CI 1.05-1.13; P <.0001). These results were consistent for a combined endpoint of all-cause mortality or hospitalization. Patient, device, and hospital characteristics associated with 3-year mortality were similar between those with and those without complications.
Among Medicare beneficiaries, the occurrence of complications within 90 days of ICD implantation was associated with increased risk of all-cause mortality and all-cause mortality or hospitalization at 1 and 3 years. Patient, procedure, and hospital characteristics associated with mortality at 3 years after implantation were similar regardless of whether acute procedural complication occurred.
植入式心脏复律除颤器(ICD)植入相关并发症后长期结局和死亡率的预测因素尚不清楚。
本研究旨在确定 ICD 植入后并发症发生后的死亡率和住院风险,并确定不良结局的预测因素。
我们对 2006 年 1 月至 2010 年 3 月期间首次接受 ICD 的 Medicare 受益人的全国心血管数据注册 ICD 登记进行了回顾性队列研究。使用 Kaplan-Meier 生存分析和多变量 Cox 比例风险回归分析检查死亡率和住院率。研究了与 ICD 植入并发症后 3 年死亡率相关的协变量。
该研究队列包括 136143 名 Medicare 受益人。在索引住院期间发生并发症的患者有 7046 例(5.18%),在器械植入后 90 天内发生并发症的患者有 10005 例(7.34%)。在调整分析中,器械植入后 90 天内发生的并发症与 1 年时全因死亡率增加相关(风险比[HR] 1.13;95%置信区间[CI] 1.05-1.20;P =.006)和 3 年(HR 1.09;95% CI 1.05-1.13;P <.0001)。对于全因死亡率或住院治疗的综合终点,这些结果是一致的。与并发症发生组相比,并发症发生组与无并发症发生组在 3 年内死亡率相关的患者、器械和医院特征相似。
在 Medicare 受益人群中,ICD 植入后 90 天内发生并发症与 1 年和 3 年时全因死亡率以及全因死亡率或住院治疗的风险增加相关。无论是否发生急性手术并发症,与植入后 3 年死亡率相关的患者、手术和医院特征相似。